Novavax (NVAX) News Today $8.89 +0.27 (+3.13%) Closing price 10/14/2025 04:00 PM EasternExtended Trading$8.94 +0.04 (+0.51%) As of 10/14/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NVAX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Shah Capital pushes for Novavax’s sale on underperformance, Reuters saysOctober 14 at 5:37 PM | msn.comNovavax stock rises after major shareholder urges company saleOctober 14 at 5:37 PM | za.investing.comNovavax Major Shareholder Calls For Sale Of Company To Larger Pharma EntityOctober 14 at 5:37 PM | msn.comHedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion PotentialOctober 14 at 1:31 PM | benzinga.comAnalysts Think These Stocks Could More Than Double in Value (NVAX)Septerna, Intellia, and Novavax have garnered investor attention for their significant upside potential, but investors should beware the risks as well.October 14 at 11:54 AM | marketbeat.comShah Capital pushes for Novavax's sale on persistent underperformance, marketing misstepsOctober 14 at 6:09 AM | reuters.comNovavax (NASDAQ:NVAX) Receives Sell (D+) Rating from Weiss RatingsOctober 10, 2025 | marketbeat.comNovavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone PaymentOctober 7, 2025 | prnewswire.comShah Capital Management Has $72.52 Million Stock Position in Novavax, Inc. $NVAXOctober 7, 2025 | marketbeat.comCDC adopts individual-based decision-making for COVID-19 shotsOctober 6, 2025 | msn.comNovavax (NVAX) Is Up 10.6% After Sanofi Expands Matrix-M Licensing Agreement - Has the Bull Case Changed?October 4, 2025 | finance.yahoo.comA Fresh Look at Novavax (NVAX) Valuation After Recent Share Price ReboundOctober 3, 2025 | finance.yahoo.comInvestors Purchase Large Volume of Call Options on Novavax (NASDAQ:NVAX)October 2, 2025 | marketbeat.comNovavax (NASDAQ:NVAX) Trading 6.4% Higher - What's Next?October 1, 2025 | marketbeat.comNovavax Amends Deal With Sanofi, Broadens PartnershipSeptember 30, 2025 | msn.comNovavax Announces Progress on Sanofi AgreementSeptember 30, 2025 | prnewswire.comNovavax Inc. stock underperforms Thursday when compared to competitorsSeptember 25, 2025 | marketwatch.comNovavax, Inc. (NASDAQ:NVAX) Given Consensus Rating of "Hold" by BrokeragesSeptember 25, 2025 | marketbeat.comKingstone Capital Partners Texas LLC Takes $1.02 Million Position in Novavax, Inc. $NVAXSeptember 22, 2025 | marketbeat.comChallenging Market Dynamics and Regulatory Hurdles Lead to Sell Rating for NovavaxSeptember 21, 2025 | tipranks.comNovavax: Endlessly Frustrating, Endlessly Fascinating - Warrants Rating UpgradeSeptember 18, 2025 | seekingalpha.comThe Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its DebutSeptember 18, 2025 | investors.comU.S. health insurers pledge continuing coverage of COVID shots ahead of ACIP meetingSeptember 17, 2025 | msn.comNovavax (NASDAQ:NVAX) Trading Up 5.1% - Time to Buy?September 17, 2025 | marketbeat.comGoldman Sachs Group Inc. Has $5.25 Million Stake in Novavax, Inc. $NVAXSeptember 17, 2025 | marketbeat.comWhy Avoid Pfizer, BioNTech, Novavax, and ModernaSeptember 15, 2025 | baystreet.caBayforest Capital Ltd Purchases New Stake in Novavax, Inc. $NVAXSeptember 13, 2025 | marketbeat.comPark West Asset Management LLC Acquires New Position in Novavax, Inc. $NVAXSeptember 8, 2025 | marketbeat.comNorthern Trust Corp Reduces Position in Novavax, Inc. $NVAXSeptember 8, 2025 | marketbeat.comNovavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 TranscriptSeptember 4, 2025 | seekingalpha.comNuvaxovid® Now Approved in Japan Triggering Takeda Milestone PaymentSeptember 4, 2025 | prnewswire.comNovavax ‘applauds’ President Trump’s call for available COVID-19 vaccine dataSeptember 4, 2025 | msn.comNovavax to Participate in the Cantor Global Healthcare ConferenceSeptember 3, 2025 | finance.yahoo.comOMERS ADMINISTRATION Corp Takes $1.28 Million Position in Novavax, Inc. $NVAXSeptember 3, 2025 | marketbeat.comOptimistic Outlook on Novavax: Strategic Positioning and Vaccine Developments Drive Buy RatingSeptember 2, 2025 | tipranks.comRafferty Asset Management LLC Sells 80,502 Shares of Novavax, Inc. $NVAXSeptember 2, 2025 | marketbeat.comInvesco Ltd. Boosts Stake in Novavax, Inc. $NVAXSeptember 2, 2025 | marketbeat.comFY2025 Earnings Forecast for Novavax Issued By HC WainwrightSeptember 2, 2025 | marketbeat.comNuveen LLC Purchases New Position in Novavax, Inc. $NVAXSeptember 1, 2025 | marketbeat.comNovavax, Inc. (NASDAQ:NVAX) Given Consensus Recommendation of "Hold" by BrokeragesSeptember 1, 2025 | marketbeat.comQ3 Earnings Forecast for Novavax Issued By HC WainwrightAugust 31, 2025 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Novavax (NASDAQ:NVAX)August 30, 2025 | marketbeat.comKohl’s, Bill.com, Novavax, Jazz, Nvidia: Trending by AnalystsAugust 30, 2025 | tipranks.comNovavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLAAugust 29, 2025 | finance.yahoo.comRobert Kennedy Jr. Announces End Of FDA Covid Mandates – Clears Moderna, Pfizer, Novavax For High-Risk GroupsAugust 28, 2025 | msn.comNovavax (NVAX) Is Up After FDA Approves Updated Nuvaxovid for Key High-Risk Groups—What's ChangedAugust 28, 2025 | finance.yahoo.comNovavax, Inc. (NVAX) Launches Protein-Based Vaccine for High-Risk AdultsAugust 28, 2025 | insidermonkey.com511,742 Shares in Novavax, Inc. $NVAX Purchased by Jump Financial LLCAugust 28, 2025 | marketbeat.comRFK Jr. Rescinds Emergency Authorizations For COVID-19 VaccinesAugust 27, 2025 | benzinga.comNovavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.August 27, 2025 | prnewswire.com Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NVAX Media Mentions By Week NVAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVAX News Sentiment▼0.310.72▲Average Medical News Sentiment NVAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVAX Articles This Week▼911▲NVAX Articles Average Week Get the Latest News and Ratings for NVAX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Novavax and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Moderna News Ocugen News Vaxart News Johnson & Johnson News Pfizer News Alkermes News Ligand Pharmaceuticals News Amicus Therapeutics News Celldex Therapeutics News MannKind News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVAX) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novavax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
